FDA has proposed restrictions on the sale and distribution of electronic cigarettes (e-cigarettes) and other vapor-inhalation tobacco products to patients younger than 18 years, and requiring the full disclosure of all ingredients on package labels for e-cigarettes and other vaporized nicotine products. On August 8, APhA submitted comments to the agency that reflected APhA members’ support of the proposed rule and offered specific feedback on FDA’s request for more information on how e-cigarettes are used.